Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene Technology

Oxford Gene Technology has extended its Chip2 family of ChIP-on-chip microarray products with the addition of four prokaryote species. These include Escherichia coli 0157, Salmonella typhimurium LT2, S. typhimurium SL1344, and Streptomyces coelicolor.  
The Chip2 microarrays can be used to identify the binding positions of global DNA-binding proteins, analyze changes in a particular protein’s binding under “various environmental conditions,” or to reveal potential therapeutic targets against a prokaryotic species.   
Each Chip2 microarray is fabricated using OGT’s ink-jet in situ synthesis platform and interrogates the genome of interest with a probe density of 22,000 oligonucleotide features.

ChIP microarray data generated can then be analyzed in relation to its relative gene position using an OGT-developed ChIP browser.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.